Modulation of cytotoxic responses by targeting CD160 prolongs skin graft survival across major histocompatibility class I barrier

1. del Rio, M.-L.
2. Bravo Moral, A.M.
3. Fernandez-Renedo, C.
4. Buhler, L.
5. Perez-Simon, J.-A.
6. Chaloin, O.
7. Alvarez Nogal, R.
8. Fernandez-Caso, M.
9. Rodriguez-Barbosa, J.-I.